115 related articles for article (PubMed ID: 8856640)
1. Reactive arthritis associated with bacillus Calmette-Guérin immunotherapy for carcinoma of the bladder: immune reactivity against mycobacterial antigens.
Miossec P
J Rheumatol; 1996 Aug; 23(8):1485. PubMed ID: 8856640
[No Abstract] [Full Text] [Related]
2. Complications of bacillus Calmette-Guerin (BCG) immunotherapy in superficial bladder cancer.
Sosnowski JT
Compr Ther; 1994; 20(12):695-701. PubMed ID: 7882653
[No Abstract] [Full Text] [Related]
3. [Reiter syndrome after intravesical Bacillus Calmette-Guerin (BCG) immunotherapy: a case report].
Shiba M; Fujii T; Takatera H
Hinyokika Kiyo; 2003 Oct; 49(10):599-601. PubMed ID: 14655604
[TBL] [Abstract][Full Text] [Related]
4. Reactive arthritis associated with Bacillus Calmette-Guerin immunotherapy for carcinoma of the bladder: a report of two cases.
Jawad AS; Kahn L; Copland RF; Henderson DC; Abdul-Ahad AK
Br J Rheumatol; 1993 Nov; 32(11):1018-20. PubMed ID: 8220923
[No Abstract] [Full Text] [Related]
5. New-onset psoriasis and psoriatic arthritis in a patient treated with Bacillus Calmette-Guérin (BCG) immunotherapy.
Dudelzak J; Curtis AR; Sheehan DJ; Lesher JL
J Drugs Dermatol; 2008 Jul; 7(7):684. PubMed ID: 18664162
[No Abstract] [Full Text] [Related]
6. Arthritis associated with adjuvant mycobacterial treatment for carcinoma of the bladder.
Chapman PT; Mark SD; Moller PW
N Z Med J; 1992 Feb; 105(927):37-8. PubMed ID: 1538864
[No Abstract] [Full Text] [Related]
7. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
[TBL] [Abstract][Full Text] [Related]
8. Tubercular prostatic abscess as a complication of intravesical bacillus Calmette-Guérin immunotherapy.
Aust TR; Massey JA
Int J Urol; 2005 Oct; 12(10):920-1. PubMed ID: 16323989
[TBL] [Abstract][Full Text] [Related]
9. [Squamous cell carcinoma of the urinary bladder after intravesical bacillus Calmette-Guerin therapy for carcinoma in situ: a case report].
Uemura M; Nishimura K; Nakagawa M; Kanno N; Miyoshi S; Kawano K; Inoue H
Hinyokika Kiyo; 2004 Nov; 50(11):809-11. PubMed ID: 15628544
[TBL] [Abstract][Full Text] [Related]
10. Arthritis and iritis after BCG therapy for bladder cancer.
Price GE
J Rheumatol; 1994 Mar; 21(3):564-5. PubMed ID: 8006904
[TBL] [Abstract][Full Text] [Related]
11. Arthritis after Calmette-Guerin bacillus immunotherapy for bladder cancer.
Goupille P; Soutif D; Valat JP
J Rheumatol; 1992 Nov; 19(11):1825-6. PubMed ID: 1491413
[No Abstract] [Full Text] [Related]
12. Control group and maintenance treatment with bacillus Calmette-Guerin for carcinoma in situ and/or high grade bladder tumors.
Palou J; Laguna P; Millán-Rodríguez F; Hall RR; Salvador-Bayarri J; Vicente-Rodríguez J
J Urol; 2001 May; 165(5):1488-91. PubMed ID: 11342902
[TBL] [Abstract][Full Text] [Related]
13. [Relapsing Reiter's syndrome after Bacillus Calmette-Guérin immunotherapy for bladder carcinoma].
Pego JM; Lamas C; Hernández I; Suso J
Med Clin (Barc); 2003 Sep; 121(9):356-7. PubMed ID: 14499076
[No Abstract] [Full Text] [Related]
14. Superficial bladder tumors and increased reactivity against mycobacterial antigens before bacillus Calmette-Guerin therapy.
Zlotta AR; Drowart A; Van Vooren JP; Shekarsarai H; De Cock M; Pirson M; Palfliet K; Jurion F; Simon J; Schulman CC; Huygen K
J Urol; 1998 Jun; 159(6):1885-91. PubMed ID: 9598481
[TBL] [Abstract][Full Text] [Related]
15. Purulent abscess after bacillus Calmette-Guerin therapy for bladder cancer.
Konrad K; Földes K
J Rheumatol; 1995 Jul; 22(7):1441. PubMed ID: 7562797
[No Abstract] [Full Text] [Related]
16. Sepsis and granulomatous hepatitis after bacillus Calmette-Guerin intravesical installation.
Trevenzoli M; Cattelan AM; Marino F; Sasset L; Donà S; Meneghetti F
J Infect; 2004 May; 48(4):363-4. PubMed ID: 15066339
[No Abstract] [Full Text] [Related]
17. Mycobacterium bovis-BCG infection of the glans penis: a complication of intravesical administration of bacillus Calmette-Guerin.
Ribera M; Bielsa J; Manterola JM; Fernández MT; Ferrándiz C
Br J Dermatol; 1995 Feb; 132(2):309-10. PubMed ID: 7888373
[No Abstract] [Full Text] [Related]
18. [A case of interstitial pneumonitis caused by intravesical bacillus Calmette-Guérin instillation].
Horinaga M; Nakamura K; Nishiyama T; Murai M
Hinyokika Kiyo; 1999 Jul; 45(7):493-5. PubMed ID: 10466068
[TBL] [Abstract][Full Text] [Related]
19. Bladder and penile lesions with inguinal adenopathy after intravesical Bacillus Calmette-Guerin (BCG) treatment.
Yates J; Stein B
Urology; 2007 Dec; 70(6):1223.e15-7. PubMed ID: 18158061
[TBL] [Abstract][Full Text] [Related]
20. Miliary tuberculosis of the lung in a patient treated with bacillus Calmette-Guerin for superficial bladder cancer.
Iantorno R; Nicolai M; Storto ML; Ciccotosto C; Cipollone G; Mastroprimiano G; Tenaglia RL
J Urol; 1998 May; 159(5):1639-40. PubMed ID: 9554372
[No Abstract] [Full Text] [Related]
[Next] [New Search]
